MEDICLIN Aktiengesellschaft (MED) — Cash Flow Reinvestment Rate
MEDICLIN Aktiengesellschaft (MED) has a Cash Flow Reinvestment Rate of 0.53x as of December 2025, reinvesting €12.76 Million (capex €12.76 Million ) from operating cash flow of €24.23 Million. Explore MED capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
MEDICLIN Aktiengesellschaft Cash Flow Reinvestment Rate (2003–2025)
Historical reinvestment intensity for MEDICLIN Aktiengesellschaft across 23 annual periods. Also explore balance sheet size of MEDICLIN Aktiengesellschaft for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for MEDICLIN Aktiengesellschaft (2003–2025)
Year-by-year capital reinvestment analysis for MEDICLIN Aktiengesellschaft. For live market cap and broader valuation context, see MEDICLIN Aktiengesellschaft (MED) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.48x | €48.43 Million | €99.87 Million | €48.43 Million | ▼ -34.7% |
| 2024 | 0.74x | €59.82 Million | €80.57 Million | €44.69 Million | ▲ +49.3% |
| 2023 | 0.50x | €38.79 Million | €78.00 Million | €37.58 Million | ▼ -46.6% |
| 2022 | 0.93x | €32.26 Million | €34.64 Million | €26.02 Million | ▲ +216.8% |
| 2021 | 0.29x | €24.10 Million | €81.97 Million | €17.01 Million | ▲ +35.3% |
| 2020 | 0.22x | €25.79 Million | €118.69 Million | €25.78 Million | ▼ -66.4% |
| 2019 | 0.65x | €44.97 Million | €69.59 Million | €44.93 Million | ▼ -58.7% |
| 2018 | 1.57x | €46.47 Million | €29.68 Million | €46.42 Million | ▼ -15.3% |
| 2017 | 1.85x | €35.74 Million | €19.34 Million | €35.72 Million | ▲ +25.4% |
| 2016 | 1.47x | €44.06 Million | €29.90 Million | €26.15 Million | ▲ +64.2% |
| 2015 | 0.90x | €25.96 Million | €28.92 Million | €25.92 Million | ▲ +44.1% |
| 2014 | 0.62x | €20.01 Million | €32.13 Million | €19.98 Million | ▼ -62.8% |
| 2013 | 1.68x | €16.68 Million | €9.95 Million | €16.63 Million | ▲ +9.5% |
| 2012 | 1.53x | €24.75 Million | €16.17 Million | €24.75 Million | ▼ -13.1% |
| 2011 | 1.76x | €27.52 Million | €15.63 Million | €27.52 Million | ▲ +10.4% |
| 2010 | 1.60x | €21.32 Million | €13.37 Million | €21.32 Million | ▲ +170.4% |
| 2009 | 0.59x | €19.08 Million | €32.35 Million | €19.08 Million | ▼ -68.1% |
| 2008 | 1.85x | €39.81 Million | €21.53 Million | €39.81 Million | — |
| 2007 | 0.00x | €0.00 | €16.41 Million | €0.00 | — |
| 2006 | 0.00x | €0.00 | €13.39 Million | €0.00 | — |
| 2005 | 0.00x | €0.00 | €17.52 Million | €0.00 | ▼ -100.0% |
| 2004 | 1.73x | €19.05 Million | €11.00 Million | €19.05 Million | ▲ +25.4% |
| 2003 | 1.38x | €10.47 Million | €7.58 Million | €10.47 Million | — |